Financials

  • Market Capitalization 19.68 M
  • Employee 5
  • Founded 1979
  • CEO N/A
  • Website www.dyadic.com
  • Headquarter Delaware, United States
  • FIGI BBG000L276R1
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-4.27
Rapporto prezzo/fatturato

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4557
LEXX
Lexaria Bioscience Corp. - Common Stock
12.48 USD+11.93%+6.67%+111.53%+1302.25%20.62 M USD
4562
CMMB
Chemomab Therapeutics Ltd - American Depositary Shares
2.72 USD0.00%+18.26%+70.00%+84.41%19.56 M USD
4574
AKTX
Akari Therapeutics Plc - American Depositary Shares
10.37 USD-0.58%+28.02%+38.08%+1246.75%20.19 M USD
4575
LPCN
Lipocine Inc. - Common Stock
2.29 USD+2.23%+6.51%+2.23%-21.03%18.88 M USD

Notizie